Search results
Bear of the Day: CVS Health (CVS)
Zacks via Yahoo Finance· 2 days agoDrugstore giant CVS faces numerous bearish headwinds, which are industry and company-specific. Investors should avoid shares over the next 6-12 months.
CMS: U.S. employers to spend $1.3T on health benefits this year
BenefitsPRO· 6 days agoThe CMS national health expenditure team prepares the spending forecasts to help policymakers at ...
Americans stash funds in HSAs amid Medicare trust fund concerns
The Escanaba Daily Press· 2 days agoAmericans are increasingly taking control of saving and investing for their healthcare expenses...
Why Bernie Sanders’ Ozempic crusade is misguided
Dallas Morning News· 23 hours agoIn the Vermont independent’s capacity as chairman of the Senate Health, Education, Labor and Pensions Committee, Sanders sent a letter to the CEO of Novo...
High Out-of-Pocket Costs Keep Some From Lifesaving Opioid Antidote
US News & World Report· 19 hours agoPatients are less likely to fill prescriptions for the overdose-reversing drug naloxone when they have to shell out more at the pharmacy, a new study finds. Naloxone (also known by the brand ...
Intensive Lifestyle Change Improves Alzheimer's Symptoms
Medscape· 1 day agoHealthy behaviors have been linked to a lower risk for Alzheimer's disease (AD) but may also benefit...
Teva in talks to settle US lawsuit alleging MS drug kickbacks
Reuters· 2 days ago, opens new tab said it is in active talks to settle a U.S. Department of Justice lawsuit alleging...
CMMI’s savings record sparks concern among lawmakers
Healthcare Dive· 5 days agoThe Center for Medicare and Medicaid Innovation, or CMMI, was created by the Affordable Care Act more than a decade ago. The center is tasked with testing new healthcare payment ...
US health care costs to hit $8 trillion in 10 years: Report
WPIX New York City, NY via Yahoo News· 5 days ago“Among the major payers, Medicare has the highest projected ten-year average spending growth rate,...
US Drug Negotiations Plan Shifts Focus for Rare Disease Programs
Bloomberg Law· 2 days agoThe rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development of drugs to treat ...